ReviewHealthcare (Basel, Switzerland)2024

Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment: A Narrative Literature Review.

Michele Basilicata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.